PMNNasdaqPharmaceutical PreparationsFiscal year ends December 31
ProMIS Neurosciences Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$8.23+0.08 (+0.98%)
Close on Oct 19, 2026
- Market cap
- $75.24M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$2.71 (−24.77%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $75.24M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.52
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$42.23M
- EPS, diluted
- -$12.68
- Book value per share
- $5.40
- Diluted shares
- 9M
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Operating income
-$43.43M
Net income
-$42.23M
EPS, diluted
-$12.68
Free cash flow
–
Reported periodTrailing twelve months